FDA recall, , Moderate risk
ARUP Laboratories Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were collected from a donor taking an unlicensed, unapproved, or experimental medication.
Recall ended Sep 21, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
ARUP Laboratories, Inc. began a recall of Red Blood Cells, Leukocytes Reduced on March 28, 2026, because the product was collected from a donor taking an unlicensed, unapproved, or experimental medication. The FDA added the recall to its Enforcement Report and classified it on September 21, 2026, and listed it in its weekly enforcement report on September 30, 2026. The recall involves product distributed in Utah.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- ARUP Laboratories, Inc.
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99665
- Recall number
- B-0241-2026
All recalls from ARUP Laboratories, Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
